Uterine fibroids (UFs) are the most common benign tumors affecting women, with an estimated 70-80% of women developing fibroids by their 50s. While many fibroids remain asymptomatic, they can significantly impact quality of life when symptoms arise. The most common clinical manifestations include abnormal uterine bleeding (AUB), pelvic pain, bulk-related symptoms such as bladder or bowel compression, and, in some cases, reproductive challenges. Given their high prevalence and potential for severe symptoms, effective diagnosis and management strategies are essential.
A recent review, An Update on the Management of Uterine Fibroids: Personalized Medicine or Guidelines?, explores the latest advancements in understanding and treating uterine fibroids. The study highlights that while various medical and surgical treatments exist, effective diagnosis remains the foundation for developing a personalized approach to care.
The review emphasizes that transvaginal ultrasound (TVUS) is the first-line imaging modality for diagnosing uterine fibroids. TVUS provides a reliable and cost-effective means of assessing fibroid size, number, and location. To improve standardization in reporting ultrasound findings, several classification systems have been introduced, including:
While TVUS is sufficient in most cases, complementary imaging techniques such as magnetic resonance imaging (MRI) may be required for large fibroids, atypical presentations, or when distinguishing fibroids from other uterine pathologies. The study also discusses emerging technologies such as contrast-enhanced ultrasound and elastography, which may further refine fibroid assessment in the future.
Once a diagnosis is established, treatment decisions are guided by symptom severity, patient preferences, and reproductive goals. The study underscores the importance of personalized medicine in fibroid management, as treatment response varies depending on the fibroid’s biological characteristics.
Since ultrasound is the primary imaging tool for identifying and evaluating uterine fibroids, proper training is essential for healthcare providers. The GYN Ultrasound of Nonpregnant Abnormal Uterus – Advanced Clinical Training Parts I & II from SonoSim provide in-depth education on recognizing and assessing myometrial abnormalities, including fibroids. This training module covers both transabdominal and transvaginal ultrasound techniques, helping practitioners develop the necessary skills to perform comprehensive fibroid evaluations. By incorporating real-patient cases and standardized pathology, SonoSim helps learners develop the skills needed to accurately identify and classify uterine fibroids. Check out SonoSim’s OB/GYN training to explore this and other gynecologic ultrasound training solutions.